Showing results (71-80 of 183) with videos related to

Sort By:
Pageof 19
Drug and Alcohol Dependence|May 14, 2011
Post-marketing surveillance of buprenorphine-naloxone in Australia: diversion, injection and adherence with supervised dosingBriony Larance, Louisa Degenhardt, Nick Lintzeris, et al.
Psychopharmacology|January 22, 2003
Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteersCaroline Bell, Sue Wilson, Ann Rich, et al.
Human Psychopharmacology|October 31, 2002
GABAAbenzodiazepine receptor (GBzR) sensitivity: test-retest reliability in normal volunteersJohn Potokar, John Nash, John Sandford, et al.
BMJ Open|September 22, 2020
So near yet so far: why won't the UK prescribe medical cannabis?David Nutt, Steve Bazire, Lawrence D Phillips, et al.
Journal of Psychopharmacology (Oxford, England)|October 22, 2025
Self-treatment of psychiatric conditions using ketamine: Patterns, characteristics, and retrospective insightsGabrielle Smith, Timothy Piatkowski, Jason Ferris, et al.
Journal of Sex Research|January 16, 2026
Psychedelics and Sexual Trauma: Effects on Communication and Emotional ConnectionMason Levey, Benjamin Bonenti, Timothy Piatkowski, et al.
Human Psychopharmacology|July 25, 2013
Substitutional potential of mephedrone: an analysis of the subjective effectsMáté Kapitány-Fövény, Máté Kertész, Adam Winstock, et al.
American Journal of Lifestyle Medicine|December 22, 2025
Understanding Age-Based Differences in Psychosocial Harms, Physical Harms, and Access Difficulties Among an International Sample of Men Who Use Anabolic-Androgenic SteroidsBenjamin Bonenti, Vigorous Steve, Cheneal Puljević, et al.
Journal of Psychopharmacology (Oxford, England)|April 30, 2015
European rating of drug harmsJan van Amsterdam, David Nutt, Lawrence Phillips, et al.
Pageof 19